About Harvard Bioscience
Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization, Websites, catalogs and through distributors. The Company's product range is organized into three commercial product families: Cell and Animal Physiology (CAP), Lab Products and Services (LPS), and Molecular Separation and Analysis (MSA). The Company sells these products under brand names, including Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI and CMA Microdialysis. The Company's products consist of instruments, consumables and systems that are made up of various individual products.
Industry, Sector and Symbol:
- Sector: Computer and Technology
- Industry: Medical Instruments & Supplies
- Sub-Industry: Life Sciences Tools & Services
- Exchange: NASDAQ
- Symbol: HBIO
- CUSIP: 41690610
- Previous Close: $2.90
- 50 Day Moving Average: $3.01
- 200 Day Moving Average: $2.70
- 52-Week Range: $34,374,000.00 - $2.25
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 15.26
- P/E Growth: 1.81
- Market Cap: $99.68M
- Outstanding Shares: 34,374,000
- Beta: 1.11
- Net Margins: -18.90%
- Return on Equity: 3.73%
- Return on Assets: 2.48%
Companies Related to Harvard Bioscience:
- Debt-to-Equity Ratio: 0.17%
- Current Ratio: 3.20%
- Quick Ratio: 1.73%
What is Harvard Bioscience's stock symbol?
Harvard Bioscience trades on the NASDAQ under the ticker symbol "HBIO."
Where is Harvard Bioscience's stock going? Where will Harvard Bioscience's stock price be in 2017?
2 brokerages have issued 12 month price objectives for Harvard Bioscience's shares. Their forecasts range from $5.50 to $6.00. On average, they expect Harvard Bioscience's share price to reach $5.75 in the next twelve months.
When will Harvard Bioscience announce their earnings?
Harvard Bioscience is scheduled to release their next quarterly earnings announcement on Thursday, April, 27th 2017.
Who owns Harvard Bioscience stock?
Harvard Bioscience's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include First Light Asset Management LLC (7.98%), Dimensional Fund Advisors LP (4.69%), Royce & Associates LP (4.40%), Glacier Peak Capital LLC (3.36%), Jupiter Asset Management Ltd. (2.48%) and Renaissance Technologies LLC (1.54%). Company insiders that own Harvard Bioscience stock include David Green, Earl R Lewis, George Uveges, Jeffrey Duchemin, John F Kennedy and Robert E Gagnon.
Who sold Harvard Bioscience stock? Who is selling Harvard Bioscience stock?
Harvard Bioscience's stock was sold by a variety of institutional investors in the last quarter, including Royce & Associates LP, First Light Asset Management LLC, GSA Capital Partners LLP, Bard Associates Inc. and Jupiter Asset Management Ltd.. Company insiders that have sold Harvard Bioscience stock in the last year include David Green and Earl R Lewis.
Who bought Harvard Bioscience stock? Who is buying Harvard Bioscience stock?
Harvard Bioscience's stock was purchased by a variety of institutional investors in the last quarter, including Glacier Peak Capital LLC, GRT Capital Partners L.L.C., Renaissance Technologies LLC and Dimensional Fund Advisors LP. Company insiders that have bought Harvard Bioscience stock in the last two years include George Uveges, Jeffrey Duchemin, John F Kennedy and Robert E Gagnon.
How do I buy Harvard Bioscience stock?
Shares of Harvard Bioscience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Harvard Bioscience stock cost?
One share of Harvard Bioscience stock can currently be purchased for approximately $2.90.